Recap: Autolus Therapeutics Q4 Earnings

 

Autolus Therapeutics AUTL reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Autolus Therapeutics reported in-line EPS of $-0.51 versus an estimate of $-0.51.

Revenue was down $224.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 5.04% drop in the share price the next day.

Here's a look at Autolus Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.51 -0.50 -0.60  
EPS Actual -0.47 -0.47 -0.53 -0.83
Revenue Estimate 250.00K 190.00K 340.00K 340.00K
Revenue Actual 236.00K 1.65M 269.00K 404.00K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!